PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Lang, Irene
TI  - Subgroup Analysis of BENEFiT Trial to Evaluate Effect of Bosentan for Patients with CTEPH
DP  - 2007 Nov 01
TA  - MD Conference Express
PG  - 14--15
VI  - 7
IP  - 5
4099  - http://mdc.sagepub.com/content/7/5/14.short
4100  - http://mdc.sagepub.com/content/7/5/14.full
AB  - This article discusses results of a pre-defined subgroup analysis from the bosentan for inoperable chronic thromboembolic pulmonary hypertension [BENEFiT] trial. The BENEFiT study is the first double-blind, placebo-controlled trial designed to evaluate the safety and efficacy of bosentan for patients with inoperable chronic thromboembolic pulmonary hypertension, one of the leading causes of pulmonary arterial hypertension.